Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Abbott and Caprion extend discovery partnership in oncology

June 11, 2007

Japanese priority review for Taxotere in hormone refractory prostate cancer

June 8, 2007

Ongoing phase I clinical trials evaluating different dose schedules of E-7974

June 8, 2007

Antisense p53 production inhibitor improves efficacy and tolerability of cytarabine/idarubicin

June 8, 2007

Targeted chemotherapeutic EC-145 advances to phase II clinical trials

June 8, 2007

Tapestry's third-generation taxane TPI-287 advances through the pipeline

June 8, 2007

PF-562271 associated with activity and manageable toxicity in ongoing phase I trial

June 8, 2007

Phase III enrollment stopped for SECTA therapy on DMC advice

June 8, 2007

Heat shock protein 70 gene therapy safe, effective in phase I cancer study

June 8, 2007

Fractionated dose schedule and addition of methylphenidate reduces MLN-8054-related somnolence

June 7, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026